Literature DB >> 10518644

Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1.

V H Lee1, C Chu, E D Mahlin, S K Basu, D K Ann, M B Bolger, I S Haworth, A K Yeung, S K Wu, S Hamm-Alvarez, C T Okamoto.   

Abstract

Non-invasive delivery of peptide and protein drugs will soon become a reality. This is due partly to a better understanding of the endogenous transport mechanisms, including paracellular transport, endocytosis, and carrier-mediated transport of mucosal routes of peptide and protein drug administration. This paper focuses on work related to the elucidation of structure-function, intracellular trafficking, and regulation of the intestinal dipeptide transporter, PepT1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518644     DOI: 10.1016/s0168-3659(99)00030-9

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

Review 1.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

2.  Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein.

Authors:  D Sun; C P Landowski; X Chu; R Wallsten; T E Komorowski; D Fleisher; G L Amidon
Journal:  AAPS PharmSci       Date:  2001

Review 3.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

4.  Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporter.

Authors:  Liya Xu; Ian S Haworth; Ashutosh A Kulkarni; Michael B Bolger; Daryl L Davies
Journal:  Pharm Res       Date:  2009-08-14       Impact factor: 4.200

Review 5.  Molecular modeling of PepT1--towards a structure.

Authors:  D Meredith; R A Price
Journal:  J Membr Biol       Date:  2007-04-06       Impact factor: 1.843

Review 6.  The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology.

Authors:  Hannelore Daniel; Gabor Kottra
Journal:  Pflugers Arch       Date:  2003-08-07       Impact factor: 3.657

7.  Structural snapshots of human PepT1 and PepT2 reveal mechanistic insights into substrate and drug transport across epithelial membranes.

Authors:  Maxime Killer; Jiri Wald; Joanna Pieprzyk; Thomas C Marlovits; Christian Löw
Journal:  Sci Adv       Date:  2021-11-03       Impact factor: 14.136

8.  Expression of intestinal transporter genes in beagle dogs.

Authors:  Soo-Min Cho; Sung-Won Park; Na-Hyun Kim; Jin-A Park; Hee Yi; Hee-Jung Cho; Ki-Hwan Park; Ingyun Hwang; Ho-Chul Shin
Journal:  Exp Ther Med       Date:  2012-10-30       Impact factor: 2.447

9.  The transmembrane tyrosines Y56, Y91 and Y167 play important roles in determining the affinity and transport rate of the rabbit proton-coupled peptide transporter PepT1.

Authors:  Myrtani Pieri; Christine Gan; Patrick Bailey; David Meredith
Journal:  Int J Biochem Cell Biol       Date:  2009-04-21       Impact factor: 5.085

10.  Mutation screening of two candidate genes from 13q32 in families affected with Bipolar disorder: human peptide transporter (SLC15A1) and human glypican5 (GPC5).

Authors:  Manjula Maheshwari; S L Christian; C Liu; J A Badner; S Detera-Wadleigh; E S Gershon; Richard A Gibbs
Journal:  BMC Genomics       Date:  2002-10-22       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.